NLRP3 inflammasome inhibition by the novel bispecific antibody inflamab inhibits atherosclerosis in apolipoprotein E-deficient mice

L. Delfos, M.A.C. Depuydt, A. Foks, M. Bernabe Kleijn, J. Kuiper, M. Chemaly, A. Peace, V. Mcgilligan, I. Bot

Research output: Contribution to journal › Meeting Abstract › peer-review

Fingerprint

Dive into the research topics of 'NLRP3 inflammasome inhibition by the novel bispecific antibody inflamab inhibits atherosclerosis in apolipoprotein E-deficient mice'. Together they form a unique fingerprint.

Immunology and Microbiology